BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 25637276)

  • 21. Radioiodination and preclinical evaluation of 4-benzyl-1-(3-[
    Sadeghzadeh M; Alirezapour B; Charkhlooie GA; Baghery MK; Khorouti A
    Ann Nucl Med; 2017 May; 31(4):335-346. PubMed ID: 28315150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiosynthesis and in vivo evaluation of novel radioligands for PET imaging of cerebral 5-HT7 receptors.
    Hansen HD; Herth MM; Ettrup A; Andersen VL; Lehel S; Dyssegaard A; Kristensen JL; Knudsen GM
    J Nucl Med; 2014 Apr; 55(4):640-6. PubMed ID: 24566002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and preliminary evaluation of [11C]NE-100 labeled in two different positions as a PET sigma receptor ligand.
    Ishiwata K; Noguchi J; Ishii S; Hatano K; Ito K; Nabeshima T; Senda M
    Nucl Med Biol; 1998 Apr; 25(3):195-202. PubMed ID: 9620623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor imaging with 2 sigma-receptor ligands, 18F-FE-SA5845 and 11C-SA4503: a feasibility study.
    van Waarde A; Buursma AR; Hospers GA; Kawamura K; Kobayashi T; Ishii K; Oda K; Ishiwata K; Vaalburg W; Elsinga PH
    J Nucl Med; 2004 Nov; 45(11):1939-45. PubMed ID: 15534066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. (18)F-Labeled 1,4-Dioxa-8-azaspiro[4.5]decane Derivative: Synthesis and Biological Evaluation of a σ1 Receptor Radioligand with Low Lipophilicity as Potent Tumor Imaging Agent.
    Xie F; Bergmann R; Kniess T; Deuther-Conrad W; Mamat C; Neuber C; Liu B; Steinbach J; Brust P; Pietzsch J; Jia H
    J Med Chem; 2015 Jul; 58(14):5395-407. PubMed ID: 26090686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and evaluation of a new vesamicol analog o-[(11)C]methyl-trans-decalinvesamicol as a PET ligand for the vesicular acetylcholine transporter.
    Kitamura Y; Kozaka T; Miwa D; Uno I; Azim MA; Ogawa K; Taki J; Kinuya S; Shiba K
    Ann Nucl Med; 2016 Feb; 30(2):122-9. PubMed ID: 26608176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluorescent derivatives of σ receptor ligand 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) as a tool for uptake and cellular localization studies in pancreatic tumor cells.
    Abate C; Hornick JR; Spitzer D; Hawkins WG; Niso M; Perrone R; Berardi F
    J Med Chem; 2011 Aug; 54(16):5858-67. PubMed ID: 21744858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and evaluation of a radiobromine-labeled sigma ligand for tumor imaging.
    Ogawa K; Kanbara H; Kiyono Y; Kitamura Y; Kiwada T; Kozaka T; Kitamura M; Mori T; Shiba K; Odani A
    Nucl Med Biol; 2013 May; 40(4):445-50. PubMed ID: 23528561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and initial PET imaging of new potential NK1 receptor radioligands 1-[2-(3,5-bis-trifluoromethyl-benzyloxy)-1-phenyl-ethyl]-4-[11C]methyl-piperazine and {4-[2-(3,5-bis-trifluoromethyl-benzyloxy)-1-phenyl-ethyl]-piperazine-1-yl}-acetic acid [11C]methyl ester.
    Gao M; Mock BH; Hutchins GD; Zheng QH
    Nucl Med Biol; 2005 Jul; 32(5):543-52. PubMed ID: 15982585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and evaluation of novel (18)F-labeled spirocyclic piperidine derivatives as σ1 receptor ligands for positron emission tomography imaging.
    Li Y; Wang X; Zhang J; Deuther-Conrad W; Xie F; Zhang X; Liu J; Qiao J; Cui M; Steinbach J; Brust P; Liu B; Jia H
    J Med Chem; 2013 May; 56(9):3478-91. PubMed ID: 23566245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiofluorinated probe for PET imaging of fatty acid binding protein 4 in cancer.
    Temma T; Nishigori K; Onoe S; Sampei S; Kimura I; Ono M; Saji H
    Nucl Med Biol; 2015 Feb; 42(2):184-91. PubMed ID: 25457456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new 18F-labeled fluoroacetylmorpholino derivative of vesamicol for neuroimaging of the vesicular acetylcholine transporter.
    Sorger D; Scheunemann M; Grossmann U; Fischer S; Vercouille J; Hiller A; Wenzel B; Roghani A; Schliebs R; Brust P; Sabri O; Steinbach J
    Nucl Med Biol; 2008 Feb; 35(2):185-95. PubMed ID: 18312828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New sigma and 5-HT1A receptor ligands: omega-(tetralin-1-yl)-n-alkylamine derivatives.
    Berardi F; Colabufo NA; Giudice G; Perrone R; Tortorella V; Govoni S; Lucchi L
    J Med Chem; 1996 Jan; 39(1):176-82. PubMed ID: 8568804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-(3,4-Dimethylisoxazol-5-yl)piperazine-4-[4-(2-fluoro-4-[(11)C]methylphenyl)thiazol-2-yl]-1-carboxamide: A promising positron emission tomography ligand for fatty acid amide hydrolase.
    Shimoda Y; Fujinaga M; Hatori A; Yui J; Zhang Y; Nengaki N; Kurihara Y; Yamasaki T; Xie L; Kumata K; Ishii H; Zhang MR
    Bioorg Med Chem; 2016 Feb; 24(4):627-34. PubMed ID: 26740152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two C-methyl derivatives of [11C]WAY-100635--effects of an amido alpha-methyl group on metabolism and brain 5-HT1A receptor radioligand behavior in monkey.
    McCarron JA; Marchais-Oberwinkler S; Pike VW; Tarkiainen J; Halldin C; Sóvagó J; Gulyas B; Wikström HV; Farde L
    Mol Imaging Biol; 2005; 7(3):209-19. PubMed ID: 15912425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 11C-labeling of n-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl]arylcarboxamide derivatives and evaluation as potential radioligands for PET imaging of dopamine D3 receptors.
    Turolla EA; Matarrese M; Belloli S; Moresco RM; Simonelli P; Todde S; Fazio F; Magni F; Kienle MG; Leopoldo M; Berardi F; Colabufo NA; Lacivita E; Perrone R
    J Med Chem; 2005 Nov; 48(22):7018-23. PubMed ID: 16250661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and evaluation in rats of the dopamine D2/3 receptor agonist 18F-AMC20 as a potential radioligand for PET.
    Shalgunov V; van Wieringen JP; Janssen HM; Fransen PM; Dierckx RA; Michel MC; Booij J; Elsinga PH
    J Nucl Med; 2015 Jan; 56(1):133-9. PubMed ID: 25476538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sigma-2 receptor agonist derivatives of 1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) induce cell death via mitochondrial superoxide production and caspase activation in pancreatic cancer.
    Pati ML; Hornick JR; Niso M; Berardi F; Spitzer D; Abate C; Hawkins W
    BMC Cancer; 2017 Jan; 17(1):51. PubMed ID: 28086830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of a novel iodinated sigma-2 receptor ligand as a cell proliferation marker.
    Hou C; Tu Z; Mach R; Kung HF; Kung MP
    Nucl Med Biol; 2006 Feb; 33(2):203-9. PubMed ID: 16546674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and evaluation of 1-[2-(4-[(11)C]methoxyphenyl)phenyl]piperazine for imaging of the serotonin 5-HT7 receptor in the rat brain.
    Shimoda Y; Yui J; Xie L; Fujinaga M; Yamasaki T; Ogawa M; Nengaki N; Kumata K; Hatori A; Kawamura K; Zhang MR
    Bioorg Med Chem; 2013 Sep; 21(17):5316-22. PubMed ID: 23830697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.